TruthArchive.ai - Tweets Saved By @DrHermiz

Saved - November 16, 2023 at 11:20 AM
reSee.it AI Summary
Dr. Peter Daszak, President of the EcoHealth Alliance, explains that coronaviruses can be easily manipulated in the lab. By studying the spike protein, which plays a crucial role in the virus's behavior and zoonotic risk, scientists can obtain its sequence and build the protein. Collaborating with Ralph Baric at UNC, they insert it into another virus to conduct further research. (297 characters)

@DrHermiz - David J Hermiz MD

"You can manipulate [coronaviruses] in the lab pretty easily. Spike protein drives a lot of what happens with the coronavirus, zoonotic risk. So you can get the sequence, you can build the protein, and we work with Ralph Baric at UNC to do this. Insert it into the backbone of another virus and do some work in the labs." -- Dr. Peter Daszak, President of the EcoHealth Alliance American Society for Microbiology. This Week in Virology Podcast. (2020, May 19). Peter Daszak of EcoHealth Alliance - TWiV 615. https://asm.org/Podcasts/TWiV/Episodes/Peter-Daszak-of-EcoHealth-Alliance-TWiV-615

Peter Daszak of EcoHealth Alliance Protecting wildlife and public health from the emergence of disease. asm.org
Saved - November 16, 2023 at 10:58 AM
reSee.it AI Summary
In 2015, UNC researchers led by Dr. Ralph Baric studied SARS-CoV variants using pseudoviruses and chimeric viruses. They manipulated plasmids to insert the spike protein gene into a viral genome, observing its effects on infection and replication. The chimeric virus replicated in human airway cells, used the human ACE2 receptor, and caused disease in mice. This highlights the risk of new SARS-CoV outbreaks from bat populations.

@DrHermiz - David J Hermiz MD

https://www.nature.com/articles/nm.3985 Researchers at UNC led by Dr. Ralph Baric in 2015 cultured SARS-CoV variants in specific cell lines to study infection patterns. This included using pseudoviruses (non-replicative, inert viruses also used in vaccine development) to assess how the virus might bind to human cells and developing growth curves to understand virus behavior in various environments. To create chimeric viruses, the researchers employed reverse genetics to manipulate plasmids—DNA molecules used to artificially introduce foreign DNA into a cell. This enabled insertion of the the spike protein gene into a viral genome and observing the resultant effects on host cell infection, virus replication, and pathogenesis in a controlled laboratory setting. This chimeric virus produced from the study was able effectively use the human ACE2 receptor, replicate in human airway cells, and cause disease in mice. Current SARS treatments were ineffective against it, indicating a risk of new SARS-CoV outbreaks from bat populations.

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence - Nature Medicine Ralph Baric, Vineet Menachery and colleagues characterize a SARS-like coronavirus circulating in Chinese horseshoe bats to determine its potential to infect primary human airway epithelial cells, cause disease in mice and respond to available therapeutics. The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome (MERS)-CoV underscores the threat of cross-species transmission events leading to outbreaks in humans. Here we examine the disease potential of a SARS-like virus, SHC014-CoV, which is currently circulating in Chinese horseshoe bat populations1. Using the SARS-CoV reverse genetics system2, we generated and characterized a chimeric virus expressing the spike of bat coronavirus SHC014 in a mouse-adapted SARS-CoV backbone. The results indicate that group 2b viruses encoding the SHC014 spike in a wild-type backbone can efficiently use multiple orthologs of the SARS receptor human angiotensin converting enzyme II (ACE2), replicate efficiently in primary human airway cells and achieve in vitro titers equivalent to epidemic strains of SARS-CoV. Additionally, in vivo experiments demonstrate replication of the chimeric virus in mouse lung with notable pathogenesis. Evaluation of available SARS-based immune-therapeutic and prophylactic modalities revealed poor efficacy; both monoclonal antibody and vaccine approaches failed to neutralize and protect from infection with CoVs using the novel spike protein. On the basis of these findings, we synthetically re-derived an infectious full-length SHC014 recombinant virus and demonstrate robust viral replication both in vitro and in vivo. Our work suggests a potential risk of SARS-CoV re-emergence from viruses currently circulating in bat populations. nature.com
Saved - November 11, 2023 at 8:19 AM

@DrHermiz - David J Hermiz MD

Dr. Peter Daszak has been ordered to testify before the US Congress in Washington D.C. on November 14, 2023, regarding his alleged involvement in the creation and accidental release of SARS-CoV-2, and his involvement in a conspiracy to cover this up. #OriginOfCovid #COVID19

@DrHermiz - David J Hermiz MD

https://t.co/M4JH54cuOS

Video Transcript AI Summary
Scientists sequence the virus and compare it to known pathogens like SARS. They discovered similar coronaviruses in bats and focused on the spike protein that attaches to cells. Chinese researchers created pseudoparticles with spike proteins from these viruses to test their binding to human cells. Each step of this process helps determine if the virus can become pathogenic in humans. Manipulating the spike protein in the lab is crucial for understanding the zoonotic risk. By obtaining the sequence, scientists can predict the virus's behavior more accurately.
Full Transcript
Speaker 0: Then then when you get a sequence of the virus, and it looks like a relative of the known nasty pathogen, just like we did with SARS, we found other coronaviruses in bats, a whole host of them. Some of them looked very similar to SARS. So we sequence the spike protein, the protein that attaches to cells. Then we well, I didn't do this work, but my colleagues in China did the work. You create pseudoparticles, you look you insert the spike proteins from those viruses, see if they're bind to human cells. And each step of this, you move cross across the 2, this virus could really become pathogenic in people. You can manipulate them in the lab pretty easily, it's just spike protein drives a lot of what happens with the coronavirus, zoonotic risk. So you can get the sequence, you can build the protein and we work with Ralph Barrick at UNC to do this, insert into backbone of another virus. Right? And do do some work in the lab. So you can get more predictive when you find a sequence.
Saved - November 11, 2023 at 4:49 AM
reSee.it AI Summary
Dr. Peter Daszak requested funding from the Defense Advanced Research Projects Agency in 2018 for a project called "Defusing the Threat of Bat-borne Coronaviruses." The project involved inserting a furin cleavage site into SARS-like coronaviruses collected from southern China's natural reservoir. This research was conducted at the Wuhan Institute of Virology. Dr. Daszak has been subpoenaed to testify in Washington D.C. on November 14, 2023, regarding his alleged involvement in the accidental release of SARS-CoV-2 and a conspiracy to cover it up.

@DrHermiz - David J Hermiz MD

Dr. Peter Daszak, as the president of the @EcoHealthNYC, submitted a funding request to the Defense Advanced Research Projects Agency (@DARPA), an agency of the United States Department of Defense (@DeptofDefense) in 2018. The title of the project was "Defusing the Threat of Bat-borne Coronaviruses." The project entailed the insertion of a furin cleavage site into SARS-like coronaviruses gathered from their natural reservoir, located 1500 km away in southern China, to the research being conducted at the Wuhan Institute of Virology. The study of the furin protease cleavage site within the spike protein of SARS-CoV-2 remains an active area of research because of its critical function in how the virus gains entry into human cells. The "furin cleavage site" refers to a segment of the spike protein in a coronavirus that interacts with the human furin enzyme, a protease that catalyzes the reaction of cleaving the spike protein, thus activating the virus for entry into the human cell. @PeterDaszak has been served a subpoena by @COVIDSelect to determine his role in the probable accidental release of #SARSCoV2 from the Wuhan Institute of Virology. He has been ordered to testify in Washington D.C. on November 14, 2023, regarding his alleged involvement in the creation and accidental release of SARS-CoV-2, the causative agent of #COVID19, and his involvement in a conspiracy to cover this up. https://www.documentcloud.org/documents/21066966-defuse-proposal

DEFUSE proposal documentcloud.org

@ydeigin - Yuri Deigin

1/ Besides the furin cleavage site (FCS), SARS2 has another unique feature mentioned in DEFUSE not yet seen in any natural SARS-like viruses – an ablated N-linked glycan at position N370. This glycan was ablated via a T372A amino acid mutation that came about via a double nucleotide mutation of the original ACT codon into GCA (the latter, incidentally, is the same codon as the one coding for alanine – out of 4 possible alanine codons – in the PRRA insertion which has created an FCS in SARS2). Importantly, the T327A mutation greatly increases SARS2 infectivity in human lung cells but, just like an FCS, this kind of a mutation seems to have selective pressure AGAINST it in ancestral bat viruses. DEFUSE’s interest in N-linked glycans stems from a very curious observation about SARS1 whose bat progenitor seems to have temporarily lost two of its N-linked glycans in civet SARS1 progenitors before re-acquiring them, and this led virologists to hypothesize that those glycans could be relevant for host switching. This is described in DEFUSE in a somewhat convoluted way: “N-linked glycosylation: Some glycosylation events regulate SARS-CoV particle binding DC-SIGN/L-SIGN, alternative receptors for SARS-CoV entry into macrophages or monocytes [76,77]. Mutations that introduced two new N-linked glycosylation sites may have been involved in the emergence of human SARS-CoV from civet and raccoon dogs [77]. While the sites are absent from civet and raccoon dog strains and clade 2 SARSr-CoV, they are present in WIV1, WIV16 and SHC014, supporting a potential role for these sites in host jumping. To evaluate this, we will sequentially introduce clade 2 disrupting residues of SARS-CoV and SHC014 and evaluate virus growth in Vero cells, nonpermissive cells ectopically expressing DC-SIGN, and in human monocytes and macrophages anticipating reduced virus growth efficiency. We will introduce the clade I mutations that result in N-linked glycosylation in rs4237 RBD deletion repaired strains, evaluating virus growth efficiency in HAE, Vero cells, or nonpermissive cells +/- ectopic DC-SIGN expression [77]. In vivo, we will evaluate pathogenesis in transgenic hACE2 mice.” The [77] paper cited in DEFUSE is a 2007 work by Han et al. titled “Specific Asparagine-Linked Glycosylation Sites Are Critical for DC-SIGN- and L-SIGN-Mediated Severe Acute Respiratory Syndrome Coronavirus Entry”. It looked at the 5 civet progenitor strains of SARS1 and showed that initially those strains did not have glycans around positions N227 and N699 but then eventually acquired them in civet progenitors and kept in human SARS1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2168787/

Specific Asparagine-Linked Glycosylation Sites Are Critical for DC-SIGN- and L-SIGN-Mediated Severe Acute Respiratory Syndrome Coronavirus Entry Severe acute respiratory syndrome (SARS) is caused by a newly emerged coronavirus (CoV) designated SARS-CoV. The virus utilizes angiotensin-converting enzyme 2 (ACE2) as the primary receptor. Although the idea is less clear and somewhat controversial, ... ncbi.nlm.nih.gov
Saved - November 11, 2023 at 2:04 AM
reSee.it AI Summary
Professor Bryce Nickels, a renowned geneticist, was blocked by the Editor-in-Chief of Nature Medicine for seeking a response to a petition signed by 5000 scientists and policymakers. The petition raised concerns about the credibility of the influential paper on the origin of COVID-19, known as "Proximal Origins." A congressional committee found that the paper's conclusions lacked verification and were influenced by politics. This raises questions about accountability and ethics in positions of influence. For more details, refer to the provided link.

@DrHermiz - David J Hermiz MD

So @Bryce_Nickels, a Professor of Genetics at Rutgers who is published in Science, Cell, Nature, and Nature Communications, gets blocked by the Editor-in-Chief of @NatureMedicine because he has been asking for a formal response to a petition signed by 5000 scientists and policymakers regarding his concerns about #ProximalOrigins, the seminal paper on the #OriginOfCovid. A congressional investigative committee already concluded, "Many of the conclusions reached by 'Proximal Origin' have never been proven or verified....Dr. Andersen made it clear that the co-authors allowed politics to influence the science behind “Proximal Origin."' When are we going to say enough is enough with people like @JMinImmunoland in these positions when they lack accountability and ethics, using their positions of influence to push their personal political agendas? How did we let these people attain these positions? https://oversight.house.gov/release/wenstrup-releases-alarming-new-report-on-proximal-origin-authors-nih-suppression-of-the-covid-19-lab-leak-hypothesis/

Wenstrup Releases Alarming New Report on “Proximal Origin” Authors, NIH Suppression of the COVID-19 Lab Leak Hypothesis - United States House Committee on Oversight and Accountability United States House Committee on Oversight and Accountability oversight.house.gov

@Bryce_Nickels - Bryce Nickels

The editor of Nature Medicine has chosen to block me rather than provide an update on the status of a letter co-signed by dozens of STEM & STEM-policy professionals we submitted 105 days ago. What does his decision reveal about transparency and ethics in scientific publishing? https://t.co/us25l0LMZo

Saved - November 11, 2023 at 1:07 AM
reSee.it AI Summary
Professor Bryce Nickels, a renowned geneticist, was blocked by the Editor-in-Chief of Nature Medicine for seeking a response to a petition signed by scientists and policymakers. The petition raised concerns about the credibility of the influential paper on the origin of COVID-19, known as Proximal Origins. A congressional committee found that the paper's conclusions lacked verification and were influenced by politics. This raises questions about accountability and ethics in positions of influence. Read more: [link]

@DrHermiz - David J Hermiz MD

So @Bryce_Nickels, a Professor of Genetics at Rutgers who is published in Science, Cell, Nature, and Nature Communications, gets blocked by the Editor-in-Chief of @NatureMedicine because he has been asking for a formal response to a petition signed by dozens of scientists and policymakers regarding his concerns about #ProximalOrigins, the seminal paper on the #OriginOfCovid. A congressional investigative committee already concluded, "Many of the conclusions reached by 'Proximal Origin' have never been proven or verified....Dr. Andersen made it clear that the co-authors allowed politics to influence the science behind “Proximal Origin."' When are we going to say enough is enough with people like @JMinImmunoland in these positions when they lack accountability and ethics, using their positions of influence to push their personal political agendas? How did we let these people attain these positions? https://oversight.house.gov/release/wenstrup-releases-alarming-new-report-on-proximal-origin-authors-nih-suppression-of-the-covid-19-lab-leak-hypothesis/

Wenstrup Releases Alarming New Report on “Proximal Origin” Authors, NIH Suppression of the COVID-19 Lab Leak Hypothesis - United States House Committee on Oversight and Accountability United States House Committee on Oversight and Accountability oversight.house.gov

@Bryce_Nickels - Bryce Nickels

The editor of Nature Medicine has chosen to block me rather than provide an update on the status of a letter co-signed by dozens of STEM & STEM-policy professionals we submitted 105 days ago. What does his decision reveal about transparency and ethics in scientific publishing? https://t.co/us25l0LMZo

Saved - November 10, 2023 at 4:34 AM
reSee.it AI Summary
In 2016, Dr. Peter Daszak discussed the process of studying viruses. By analyzing the genetic sequence of a virus, scientists can identify similarities to known pathogens. In the case of SARS, they found similar coronaviruses in bats. To understand how the virus could affect humans, researchers studied the spike protein that attaches to cells. By creating pseudo-particles and observing their interaction with human cells, they gained insights into the virus's pathogenic potential. This research sheds light on the origins of COVID-19.

@DrHermiz - David J Hermiz MD

"When you get a sequence of a virus and it looks like a relative of a known nasty pathogen, just like we did with SARS, we find other coronaviruses in bats, a whole house of them. Some of them looked very similar to SARS, so we sequenced the Spike protein—the protein that attaches to cells—then we—well, I didn't do this work, but my colleagues in China did the work—you create pseudo-particles, you insert the spike proteins from those, sift and bind to human cells. Each step of this brings you closer and closer to understanding how this virus could really become pathogenic in people." Dr. Peter Daszak, President of the EcoHealth Alliance, March 26, 2016, New York City Academy of Medicine, New York City, New York, USA, Pandemics Forum. #OriginOfCovid

View Full Interactive Feed